| dbo:assets
|
- 1.396E13 (dbd:japaneseYen)
|
| dbo:description
|
- Japanske virksomheder (da)
- companie japoneză (ro)
- perusahaan asal Jepang (in)
- syarikat Jepun (ms)
- 일본 기업 (ko)
- شركة يابانية (ar)
- Empresa japonesa (pt)
- Società giapponese (it)
- empresa japonesa (es)
- entreprise pharmaceutique japonaise (fr)
- japanisches Pharmaunternehmen (de)
- Japanese pharmaceutical company (en)
- Японская компания (ru)
- Japonya merkezli bir ilaç şirketi (tr)
- japanilainen lääkeyhtiö (fi)
- חברת תרופות יפנית (iw)
- บริษัทยาญี่ปุ่น (th)
- 日本製藥公司 (zh)
- 日本の大阪府大阪市と東京都中央区にある製薬会社 (ja)
|
| dbo:equity
|
- 6.35E12 (dbd:japaneseYen)
|
| dbo:formerName
|
- Chobei Takeda & Co., Ltd. (1925–1943) (en)
- Takeda Pharmaceutical Industries, Ltd. (English name only 1943–1961) (en)
- Takeda Chemical Industries, Ltd. (English name only 1961–2004) (en)
|
| dbo:foundingDate
|
- 1781-06-12 (xsd:date)
- 1925-01-29 (xsd:date)
|
| dbo:foundingYear
|
- 1781-01-01 (xsd:gYear)
- 1925-01-01 (xsd:gYear)
|
| dbo:industry
| |
| dbo:keyPerson
| |
| dbo:netIncome
|
- 3.1702E11 (dbd:japaneseYen)
|
| dbo:numberOfEmployees
|
- 5350 (xsd:nonNegativeInteger)
- 18378 (xsd:nonNegativeInteger)
- 49578 (xsd:nonNegativeInteger)
|
| dbo:operatingIncome
|
- 4.9051E11 (dbd:japaneseYen)
|
| dbo:originalName
| |
| dbo:revenue
|
- 4.03E12 (dbd:japaneseYen)
|
| dbo:thumbnail
| |
| dbo:type
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageWikiLink
| |
| dbp:assets
|
- (en)
- 1.396E13 (dbd:japaneseYen)
|
| dbp:equity
|
- (en)
- 6.35E12 (dbd:japaneseYen)
|
| dbp:formerName
|
- Chobei Takeda & Co., Ltd. (en)
- Takeda Chemical Industries, Ltd. (en)
- Takeda Pharmaceutical Industries, Ltd. (en)
|
| dbp:foundation
|
- 1781-06-12 (xsd:date)
- 1925-01-29 (xsd:date)
|
| dbp:founder
| |
| dbp:homepage
| |
| dbp:imageCaption
|
- Global headquarters in Nihonbashi (en)
|
| dbp:imageSize
| |
| dbp:industry
| |
| dbp:keyPeople
|
- Christophe Weber (en)
- Yasuchika Hasegawa (en)
|
| dbp:locationCity
| |
| dbp:locationCountry
| |
| dbp:logo
| |
| dbp:logoCaption
|
- Logo used since 1961 (en)
|
| dbp:name
|
- Takeda Pharmaceutical Company Limited (en)
|
| dbp:nativeName
| |
| dbp:nativeNameLang
| |
| dbp:netIncome
|
- (en)
- 3.1702E11 (dbd:japaneseYen)
|
| dbp:numEmployees
|
- 5350 (xsd:integer)
- 18378 (xsd:integer)
- 49578 (xsd:integer)
- (en)
|
| dbp:operatingIncome
|
- (en)
- 4.9051E11 (dbd:japaneseYen)
|
| dbp:owners
|
- (en)
- JPMorgan Chase (en)
- BNY Mellon (en)
- Nippon Life (en)
- State Street Corporation (en)
|
| dbp:revenue
|
- 4.03E12 (dbd:japaneseYen)
|
| dbp:romanizedName
|
- Takeda Yakuhin Kōgyō kabushiki gaisha (en)
|
| dbp:tradedAs
|
- (en)
- Nikkei 225 component (en)
- TOPIX Core30 component (en)
- NYSE:TAK (en)
|
| dbp:type
| |
| dbp:wikiPageUsesTemplate
| |
| dbp:wordnet_type
| |
| dct:subject
| |
| gold:hypernym
| |
| schema:sameAs
| |
| rdf:type
| |
| rdfs:label
|
- Takeda Pharmaceutical Company (en)
- Takeda Pharmaceutical (de)
- شركة تاكيدا الدوائية (ar)
- Takeda Pharmaceutical Company (es)
- Takeda Pharmaceutical (fr)
- Takeda Pharmaceutical Co. (it)
- Takeda Pharmaceutical Company (in)
- 다케다 약품공업 (ko)
- 武田薬品工業 (ja)
- Farmacêutica Takeda (pt)
- Takeda Pharmaceutical (ru)
- Takeda Pharmaceutical Company (uk)
- 武田藥品工業 (zh)
|
| owl:sameAs
| |
| skos:closeMatch
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:homepage
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
|
- Takeda Pharmaceutical Company Limited (en)
|
| is dbo:board
of | |
| is dbo:parentCompany
of | |
| is dbo:wikiPageDisambiguates
of | |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of |
- dbr:List_of_companies_in_the_Chicago_metropolitan_area
- dbr:Mitiglinide
- dbr:Ceftaroline_fosamil
- dbr:Febuxostat
- dbr:Idursulfase
- dbr:Mifamurtide
- dbr:Molsidomine
- dbr:Pioglitazone
- dbr:Risedronic_acid
- dbr:Ranran_Suzuki
- dbr:FTSE_100_Index
- dbr:Tomisaku_Kawasaki
- dbr:Corporation_tax_in_the_Republic_of_Ireland
- dbr:Crohn's_&_Colitis_Foundation
- dbr:Tax_inversion
- dbr:Arcturus_Therapeutics
- dbr:Melissa_Palmer
- dbr:Russell_Barkley
- dbr:National_Alliance_on_Mental_Illness
- dbr:Melatonin_receptor_agonist
- dbr:Moderna_COVID-19_vaccine
- dbr:Novavax
- dbr:List_of_pharmaceutical_compound_number_prefixes
- dbr:List_of_pharmaceutical_manufacturers_in_the_United_Kingdom
- dbr:São_Paulo_(state)
- dbr:Vienna
- dbr:Joseph_M._Juran
- dbr:Cefsulodin
- dbr:Vortioxetine
- dbr:Captain_Ultra_(TV_series)
- dbr:Takeda_(disambiguation)
- dbr:Alogliptin
- dbr:Patheon
- dbr:Naltalimide
- dbr:Sucampo_Pharmaceuticals
- dbr:Yoshiaki_Fujimori
- dbr:Lifitegrast
- dbr:The_Global_Dow
- dbr:1781
- dbr:Corporate_venture_capital
- dbr:Southeast_Region,_Brazil
- dbr:Yaroslavl
- dbr:Chūō,_Tokyo
- dbr:Deerfield,_Illinois
- dbr:Motesanib
- dbr:Mubritinib
- dbr:Voglibose
- dbr:AMAG_Pharmaceuticals
- dbr:BioMotiv
- dbr:Pharma_Documentation_Ring
- dbr:Reagan-Udall_Foundation
- dbr:Cambridge,_Massachusetts
- dbr:Chūō-ku,_Osaka
- dbr:South_East_England
- dbr:Lincolnshire,_Illinois
- dbr:Lexington,_Massachusetts
- dbr:Orally_disintegrating_tablet
- dbr:CCR5_receptor_antagonist
- dbr:Naltrexone/bupropion
- dbr:Codexis
- dbr:List_of_pharmaceutical_companies
- dbr:Idebenone
- dbr:Shingo_Yanagisawa
- dbr:Discovery_and_development_of_dipeptidyl_peptidase-4_inhibitors
- dbr:Margaret_Livingstone
- dbr:Takeda_Oncology
- dbr:TAP_Pharmaceuticals
- dbr:Johnson_&_Johnson
- dbr:Massachusetts_General_Hospital
- dbr:Nikkei_225
- dbr:Pharmaceutical_industry
- dbr:Judah_Folkman
- dbr:Nihonbashi
- dbr:Nycomed
- dbr:Nargiz_Birk-Petersen
- dbr:Direct_factor_Xa_inhibitors
- dbr:Shire_(pharmaceutical_company)
- dbr:Porter_Novelli
- dbr:Yigal_Arnon_&_Co.
- dbr:Dengue_vaccine
- dbr:Emulate
- dbr:Ixazomib
- dbr:2017_A_Lyga
- dbr:Marousi
- dbr:Hikari,_Yamaguchi
- dbr:Trilateral_Commission
- dbr:Lady_Hayakawa
- dbr:Viviana_Gradinaru
- dbr:Mitsubishi_Tanabe_Pharma
- dbr:TiGenix
- dbr:Evercore
- dbr:Namilumab
- dbr:Nathaniel_David
- dbr:Shiro_Suzuki
- dbr:Ying-Hui_Fu
- dbr:Novavax_COVID-19_vaccine
- dbr:BBC_Global_30
- dbr:American_Psychiatric_Association
- dbr:Sage_Bionetworks
- dbr:Dipeptidyl_peptidase-4_inhibitor
- dbr:Norovirus
- dbr:List_of_benzodiazepines
- dbr:Sangamo_Therapeutics
- dbr:Protein_kinase_inhibitor
- dbr:Prain_Global
- dbr:Ferdinando_Scala
- dbr:Firazorexton
- dbr:Suntinorexton
- dbr:BIOTECanada
- dbr:Innovative_Medicines_Canada
- dbr:Pharmaceutical_Advertising_Advisory_Board
- dbr:Verband_Forschender_Arzneimittelhersteller
- dbr:Arab_Pharmaceutical_Manufacturing
- dbr:Conatumumab
- dbr:Peginesatide
- dbr:Pharmaceutical_Research_and_Manufacturers_of_America
- dbr:Oronamin_C
- dbr:Alisertib
- dbr:Oxendolone
- dbr:Roivant_Sciences
- dbr:2017_LFF_I_Lyga
- dbr:Takeda
- dbr:Eugeroic
- dbr:Cenicriviroc
- dbr:List_of_Jewish_American_businesspeople
- dbr:Orteronel
- dbr:The_Samurai_(TV_series)
- dbr:Monoclonal_antibody_therapy
- dbr:Seagen
- dbr:Manufacturing_in_Japan
- dbr:Association_for_Molecular_Pathology
- dbr:Kunio_Shiota
- dbr:Apelin
- dbr:Fukuoka_Prefectural_Shuyukan_High_School
- dbr:Tedatioxetine
- dbr:Television_House
- dbr:Canadian_Association_of_Emergency_Physicians
- dbr:Deborah_Dunsire
- dbr:Fabry_disease
- dbr:Mikage_Station_(Hankyu)
- dbr:ARIAD_Pharmaceuticals
- dbr:Harvey_Berger
- dbr:Yasuyuki_Maekawa
- dbr:DTaP-IPV_vaccine
- dbr:Baxalta
- dbr:Relugolix
- dbr:Sufugolix
- dbr:Alexandria_Real_Estate_Equities
- dbr:Otsuka_Pharmaceutical
- dbr:Typhoon_Mireille
- dbr:Coalition_for_Epidemic_Preparedness_Innovations
- dbr:Foundation_for_the_National_Institutes_of_Health
- dbr:Discovery_and_development_of_angiotensin_receptor_blockers
- dbr:Discovery_and_development_of_proton_pump_inhibitors
- dbr:Lubiprostone
- dbr:Industry_in_Brazil
- dbr:Carol_Lynn_Curchoe
- dbr:Wyss_Institute_for_Biologically_Inspired_Engineering
- dbr:Hanshin_Industrial_Region
- dbr:Azilsartan
- dbr:Elacestrant
- dbr:Nereistoxin
- dbr:Mavis_Agbandje-McKenna
- dbr:Biomedical_research_in_the_United_States
- dbr:Evotec
- dbr:Schrödinger,_Inc.
- dbr:ImmunoGen
- dbr:Sarnoff_Fellowship
- dbr:Pharmaceutical_industry_in_China
- dbr:Access_to_Medicine_Index
- dbr:Eric_Gibbs
- dbr:Pharmaceutical_industry_in_India
- dbr:Antidepressants_in_Japan
- dbr:List_of_largest_Japanese_companies
- dbr:Global_Health_Innovative_Technology_Fund
- dbr:Index_of_Japan-related_articles_(T)
- dbr:MIT_Jameel_Clinic
- dbr:TAK-994
- dbr:BioLife
- dbr:URL_Pharma
- dbr:AMRI_Global
- dbr:List_of_companies_of_the_United_Kingdom_K-Z
- dbr:AR_Scientific
- dbr:武田薬品工業株式会社
- dbr:Takeda_Chemical_Industries
- dbr:Takeda_Pharma
- dbr:Takeda_Pharmaceutical
- dbr:Takeda_Pharmaceutical_Co.
- dbr:Takeda_Pharmaceutical_Co.,_Ltd.
- dbr:Takeda_Pharmaceutical_Company_Limited
- dbr:Takeda_Pharmaceuticals
- dbr:Takeda_Pharmaceuticals_Inc.
- dbr:Takeda_Pharmaceuticals_Incorporated
- dbr:Takeda_Pharmaceuticals_North_America,_Inc
- dbr:Takeda_Yakuhin_Kōgyō_Kabushiki-gaisha
|
| is dbp:boards
of | |
| is dbp:parent
of | |
| is foaf:primaryTopic
of | |
